The Exchange has sought clarification from Inventurus Knowledge Solutions Limited with respect to recent news item captioned Jhunjhunwalas-backed IKS healthcare looks to acquire TruBridge for $600 million. The response from the Company is attached.
IKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
NSE sought clarification from Inventurus Knowledge Solutions Limited (IKS) regarding a news report about a potential $600 million acquisition of TruBridge by IKS Healthcare. The company confirmed that one of its wholly-owned subsidiaries participated in discussions with TruBridge, Inc. regarding a potential acquisition. However, no definitive or binding agreements have been executed, and discussions remain non-binding and subject to various contingencies including board approvals and execution of final agreements. The company stated there is no undisclosed information requiring disclosure under SEBI regulations and will make appropriate disclosures only when material developments occur.
For now, the announcement is neutral for shareholders as no binding deal exists. The stock may see volatility if market interprets early-stage discussions as likely to progress to a formal transaction.